Back to Search
DAVID POSEY, MD
MD
Surgery Physician
NPI: 1992765853Individual
Specialties, Licenses & Credentials
Surgery PhysicianPrimary
Surgery
Code: 208600000X
C5664(AR)
Research & Publications (20)
Developing drugs for core social and communication impairment in autism.
PMID 18775370·Child Adolesc Psychiatr Clin N Am·2008
6-review
Treating autism spectrum disorders. Preface.
PMID 18775365·Child Adolesc Psychiatr Clin N Am·2008
8-other
Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.
PMID 17276750·Biol Psychiatry·2007
4-observational
High prevalence and presumptive treatment of schistosomiasis and strongyloidiasis among African refugees.
PMID 17968826·Clin Infect Dis·2007
7-preclinical
Guanfacine and guanfacine extended release: treatment for ADHD and related disorders.
PMID 18078429·CNS Drug Rev·2007
6-review
Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders.
PMID 17069548·J Child Adolesc Psychopharmacol·2006
8-other
Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: a retrospective analysis of 80 cases.
PMID 15319020·J Child Adolesc Psychopharmacol·2004
8-other
A pilot study of D-cycloserine in subjects with autistic disorder.
PMID 15514414·Am J Psychiatry·2004
3-trial
A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders.
PMID 11642476·J Child Adolesc Psychopharmacol·2001
3-trial
Autism genome-wide copy number variation reveals ubiquitin and neuronal genes.
PMID 19404257·Nature·2009
8-other
Gastrointestinal symptoms in a sample of children with pervasive developmental disorders.
PMID 18791817·J Autism Dev Disord·2009
4-observational
Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study.
PMID 19519261·J Child Adolesc Psychopharmacol·2009
3-trial
Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity.
PMID 18752063·J Autism Dev Disord·2009
2-rct
Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.
PMID 18533764·J Clin Psychiatry·2008
6-review
Cognitive effects of risperidone in children with autism and irritable behavior.
PMID 18582177·J Child Adolesc Psychopharmacol·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 501 VIRGINIA DRIVE, SUITE A
BATESVILLE, AR 72501 - Phone
- (870) 698-1846
Quick Facts
- NPI
- 1992765853
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile